This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: King Saud University. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Awwad Abdoh Radwan: Innovator in Chitosan and Triazole Compounds
Introduction
Awwad Abdoh Radwan is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of chemistry, particularly in the development of innovative compounds with potential therapeutic applications. With a total of 2 patents, Radwan's work showcases his dedication to advancing scientific knowledge and practical solutions.
Latest Patents
Radwan's latest patents include a chitosan derivative, which involves a method for its preparation and its use as an adsorption agent. This invention relates to a cross-linked thiazolidinone chitosan dibenzo crown ether, highlighting its potential as an effective adsorbent. Another significant patent focuses on triazole compounds as potential anti-inflammatory agents. This invention details a compound with specific structural characteristics, which may be utilized in therapeutic applications, particularly for treating disorders related to COX-2 inhibition.
Career Highlights
Awwad Abdoh Radwan is affiliated with King Saud University, where he contributes to research and innovation in his field. His academic and professional journey reflects a commitment to exploring new frontiers in chemistry and its applications in medicine.
Collaborations
Radwan has collaborated with esteemed colleagues, including Fars Kaed Alanazi and Ibrahim Abdallah Al-Sarra. These partnerships enhance the scope and impact of his research endeavors.
Conclusion
Awwad Abdoh Radwan stands out as an influential inventor whose work in chitosan and triazole compounds has the potential to make a significant impact in therapeutic applications. His contributions to science and collaboration with fellow researchers underscore the importance of innovation in addressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile